These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Use of continuous human and animal cell lines for the production of viral vaccines]. Grachev VP; Khapchaev IuKh Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):82-90. PubMed ID: 18368760 [TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
10. Regulatory philosophy and acceptability of cells for the production of biologicals. Petricciani JC Dev Biol Stand; 1991; 75():9-15. PubMed ID: 1794634 [TBL] [Abstract][Full Text] [Related]
11. The historical decline of tobacco smoking among United States physicians: 1949-1984. Smith DR Tob Induc Dis; 2008 Sep; 4(1):9. PubMed ID: 18822167 [TBL] [Abstract][Full Text] [Related]
12. Cell substrates: where do we stand after 50 years of discussion? Petricciani J Dev Biol (Basel); 2006; 123():11-21; discussion 55-73. PubMed ID: 16566432 [TBL] [Abstract][Full Text] [Related]
13. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review. Teżyk M; Milanowski B; Ernst A; Lulek J Drug Dev Ind Pharm; 2016 Aug; 42(8):1195-214. PubMed ID: 26592545 [TBL] [Abstract][Full Text] [Related]
14. [Science of evaluating the characteristics, quality and safety of biotechnological products: RDNA-derived products, cell culture technology-derived products, gene therapy products, cellular therapy products, and transgenic animal-derived protein products and cellular products]. Hayakawa T Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):1-38. PubMed ID: 10859934 [TBL] [Abstract][Full Text] [Related]
16. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s. Espeseth DA; Lasher H Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory changes in ruptured canine cranial and human anterior cruciate ligaments. Barrett JG; Hao Z; Graf BK; Kaplan LD; Heiner JP; Muir P Am J Vet Res; 2005 Dec; 66(12):2073-80. PubMed ID: 16379649 [TBL] [Abstract][Full Text] [Related]
18. Industry view on the relative importance of "clonality" of biopharmaceutical-producing cell lines. Frye C; Deshpande R; Estes S; Francissen K; Joly J; Lubiniecki A; Munro T; Russell R; Wang T; Anderson K Biologicals; 2016 Mar; 44(2):117-22. PubMed ID: 26852257 [TBL] [Abstract][Full Text] [Related]
19. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Lanska DJ Handb Clin Neurol; 2010; 95():445-76. PubMed ID: 19892133 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of ligament fibroblast viability in ruptured cranial cruciate ligament of dogs. Hayashi K; Frank JD; Hao Z; Schamberger GM; Markel MD; Manley PA; Muir P Am J Vet Res; 2003 Aug; 64(8):1010-6. PubMed ID: 12926594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]